United States-based drugmaker Pfizer said it would cease its vaccines sales operations in China after an import licence for one of its top-selling treatments, the only vaccine it sold in the country, was not renewed.
via South China Morning Post - Business feed http://ift.tt/1F6gBnj
No comments:
Post a Comment